Insider · CIK 0001219551

ELLBERGER LARRY

Reports to the SEC for 3 companies · NEEDHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001219551

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-06-13	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+67K sh	—	—	67,000
2017-06-15	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-06-15	CLDXCelldex Therapeutics, Inc.A Award	Director	AAward	+10K sh	—	—	73,500
2016-06-08	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-06-08	CLDXCelldex Therapeutics, Inc.A Award	Director	AAward	+10K sh	—	—	63,500
2015-08-25	CLDXCelldex Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$14.00	+$70K	53,500
2015-08-20	CLDXCelldex Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$15.00	+$75K	48,500
2015-08-18	CLDXCelldex Therapeutics, Inc.P Purchase	Director	PPurchase	+300 sh	$15.93	+$4,779	38,800
2015-08-18	CLDXCelldex Therapeutics, Inc.P Purchase	Director	PPurchase	+2,500 sh	$15.96	+$39.9K	43,500
2015-08-18	CLDXCelldex Therapeutics, Inc.P Purchase	Director	PPurchase	+2,200 sh	$15.94	+$35.1K	41,000
2015-08-13	CLDXCelldex Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$16.59	+$83K	38,500
2015-06-10	CLDXCelldex Therapeutics, Inc.A Award	Director	AAward	+6,500 sh	—	—	33,500
2015-06-10	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10.3K sh	—	—	10,300
2013-12-06	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−17.7K sh	—	—	0
2013-12-06	CLDXCelldex Therapeutics, Inc.S Sale	Director	SSale	−17.7K sh	$24.50	−$434K	25,000
2013-12-06	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.7K sh	$8.16	+$145K	42,728
2013-06-19	CLDXCelldex Therapeutics, Inc.A Award	Director	AAward	+2,000 sh	—	—	25,000
2013-06-19	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+2,000 sh	—	—	2,000
2012-06-20	CLDXCelldex Therapeutics, Inc.A Award	Director	AAward	+2,000 sh	—	—	23,000
2011-06-22	CLDXCelldex Therapeutics, Inc.A Award	Director	AAward	+2,000 sh	—	—	2,000
2010-09-22	CLDXCelldex Therapeutics, Inc.A Award	Director	AAward	+2,000 sh	—	—	2,000
2009-12-23	CLDXCelldex Therapeutics, Inc.A Award	Director	AAward	+2,000 sh	—	—	2,000
2009-11-30	CLDXCelldex Therapeutics, Inc.P Purchase	Director	PPurchase	+3,300 sh	$4.47	+$14.8K	3,300
2009-11-30	CLDXCelldex Therapeutics, Inc.P Purchase	Director	PPurchase	+1,400 sh	$4.48	+$6,272	1,400
2009-11-30	CLDXCelldex Therapeutics, Inc.P Purchase	Director	PPurchase	+300 sh	$4.46	+$1,338	300
2009-11-30	CLDXCelldex Therapeutics, Inc.P Purchase	Director	PPurchase	+7,600 sh	$4.50	+$34.2K	7,600
2009-11-30	CLDXCelldex Therapeutics, Inc.P Purchase	Director	PPurchase	+2,400 sh	$4.51	+$10.8K	2,400
2008-09-25	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2007-05-31	Omrix Biopharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	0
2007-05-31	Omrix Biopharmaceuticals, Inc.A Award	Director	AAward	+2,000 sh	—	—	2,000
2005-06-07	IDXGINTERPACE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2004-06-16	IDXGINTERPACE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500

Recent filings

Accepted (ET)
Jun 154
ELLBERGER LARRY0001179110-18-008558
SEC(opens sec.gov)
Jun 164
Celldex Therapeutics, Inc.0001179110-17-009163
SEC(opens sec.gov)
Jun 94
Celldex Therapeutics, Inc.0001179110-16-026296
SEC(opens sec.gov)
Aug 264
Celldex Therapeutics, Inc.0001179110-15-012669
SEC(opens sec.gov)
Aug 214
Celldex Therapeutics, Inc.0001179110-15-012447
SEC(opens sec.gov)
Aug 194
Celldex Therapeutics, Inc.0001179110-15-012305
SEC(opens sec.gov)
Aug 144
Celldex Therapeutics, Inc.0000905718-15-000690
SEC(opens sec.gov)
Jun 114
Celldex Therapeutics, Inc.0001179110-15-009586
SEC(opens sec.gov)
Dec 104
Celldex Therapeutics, Inc.0001179110-13-017668
SEC(opens sec.gov)
Jun 204
Celldex Therapeutics, Inc.0001179110-13-010634
SEC(opens sec.gov)
Jun 214
Celldex Therapeutics, Inc.0001179110-12-010638
SEC(opens sec.gov)
Jun 234
Celldex Therapeutics, Inc.0001179110-11-010021
SEC(opens sec.gov)

Companies

Address

C/O CELLDEX THERAPEUTICS, INC. 119 FOURTH AVENUE

NEEDHAM, MA, 02494